JAK2 EXON 12 MUTATION DETECTION / EDTA BLOOD

image not found

NABL Cap Accredited      
The JAK2 Exon 12 Mutation Detection test is a specialized molecular analysis used to identify mutations associated primarily with Polycythemia Vera and other myeloproliferative neoplasms. This mutation plays a significant role in abnormal blood cell production and helps physicians differentiate between similar blood disorders. Metropolis Healthcare performs this test using advanced PCR-based techniques for accurate mutation detection and clinical decision support. Early diagnosis helps guide appropriate treatment planning and long-term disease management

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,890.00

Sample Type: EDTA BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the JAK2 Exon 12 Mutation Detection test include?
This test analyzes the JAK2 gene segment to detect pathogenic mutations linked to myeloproliferative disorders.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses highly sensitive molecular PCR technology to identify mutations in the JAK2 exon 12 gene region.

Who should take this test?
Patients with unexplained elevated hemoglobin, high hematocrit, increased red cell mass, or suspected Polycythemia Vera should undergo this test.

What sample is required for the test?
The test requires EDTA whole blood collected under sterile conditions and processed at Metropolis Healthcare.

Is fasting needed before giving the blood sample?
No fasting is required; the sample can be given at any time.

How long does it take to receive results?
Test results are typically available within 5–7 business days at Metropolis Healthcare.

Why is this test important?
It helps confirm the diagnosis of myeloproliferative neoplasms and guides treatment decisions such as cytoreductive therapy or targeted medications.

Does Metropolis Healthcare offer additional related tests?
Yes, Metropolis Healthcare provides a comprehensive range of hematology and molecular panels, including JAK2 V617F and MPL/CALR mutation analysis

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab